Antipsychotic Medication In First-episode Psychosis: An RCT To Assess The Risk-benefit Ratio
Funder
National Health and Medical Research Council
Funding Amount
$1,141,117.00
Summary
There has been an increasing emphasis on intervening early in psychotic disorders. A fundamental principle in early intervention is “to do no harm” and benefits must outweigh the risks of treatment. While antipsychotic medication is very effective and evidence-based form of treatment for positive symptoms in most first episode psychosis (FEP) patients it has risks. This study has the potential to determine whether antipsychotic medication should be the initial treatment option for FEP.
Exploring The Meaning And Experience Of Cardiovascular Health Of People Who Live With Severe And Persistent Mental Illness.
Funder
National Health and Medical Research Council
Funding Amount
$89,114.00
Summary
People with serious mental illness die up to 25 years before their peers, mostly from cardiovascular disease. Despite extensive research, we have made little impact on addressing this health inequity. By exploring the experience and meaning of personal cardiovascular health to people with severe mental illness, this study aims to generate new knowledge that will inform the tailoring of cardiovascular health promotion interventions that meet the unique requirements of this vulnerable population.